SIMILAR PATTERNS OF AMINO ACIDS FOR 3FUP_A_MI1A1

List of similar pattern of amino acids derived from ASSAM search

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click link on the last column to view superposed patterns of amino acids in NGL viewer)
(Note that only 3-12 residue patterns can be used for ASSAM searches)
Filter list by:
Hit Macromolecule/
Organism		 Pfam Res. Interface HETATM RMSD Dali Z-score Seq. Identity (%) View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1k9a CARBOXYL-TERMINAL
SRC KINASE

(Rattus
norvegicus) 		PF00017
(SH2)
PF00018
(SH3_1)
PF07714
(Pkinase_Tyr) 		8 GLY A 207
VAL A 209
ALA A 220
LYS A 222
TYR A 268
SER A 273
LEU A 321
ASP A 332
 None
 0.80A 3fupA-1k9aA:
31.4		 3fupA-1k9aA:
25.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1nxk MAP KINASE-ACTIVATED
PROTEIN KINASE 2

(Homo sapiens) 		PF00069
(Pkinase) 		8 LEU A  70
GLY A  71
GLY A  76
VAL A  78
ALA A  91
LYS A  93
MET A 138
ASP A 207
 STU  A 401 (-3.9A)
STU  A 401 (-3.6A)
None
STU  A 401 (-4.7A)
STU  A 401 (-3.4A)
STU  A 401 ( 4.5A)
STU  A 401 (-3.2A)
STU  A 401 (-3.6A)
 0.50A 3fupA-1nxkA:
21.8		 3fupA-1nxkA:
24.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1py5 TGF-BETA RECEPTOR
TYPE I

(Homo sapiens) 		PF00069
(Pkinase)
PF08515
(TGF_beta_GS) 		9 GLY A 212
GLY A 214
GLY A 217
VAL A 219
ALA A 230
LYS A 232
TYR A 282
SER A 287
LEU A 340
 None
None
None
PY1  A 700 ( 4.7A)
PY1  A 700 (-3.5A)
PY1  A 700 (-3.9A)
PY1  A 700 (-4.6A)
None
PY1  A 700 (-4.4A)
 0.84A 3fupA-1py5A:
28.0		 3fupA-1py5A:
28.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1s9i DUAL SPECIFICITY
MITOGEN-ACTIVATED
PROTEIN KINASE
KINASE 2

(Homo sapiens) 		PF00069
(Pkinase) 		8 LEU A  78
GLY A  79
GLY A  81
GLY A  84
VAL A  86
ALA A  99
LYS A 101
MET A 147
 ATP  A 535 (-3.9A)
ATP  A 535 ( 3.9A)
ATP  A 535 (-3.8A)
ATP  A 535 ( 4.4A)
ATP  A 535 (-4.1A)
ATP  A 535 (-3.6A)
ATP  A 535 ( 2.5A)
ATP  A 535 ( 3.4A)
 0.66A 3fupA-1s9iA:
22.7		 3fupA-1s9iA:
28.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1s9i DUAL SPECIFICITY
MITOGEN-ACTIVATED
PROTEIN KINASE
KINASE 2

(Homo sapiens) 		PF00069
(Pkinase) 		8 LEU A  78
GLY A  79
GLY A  81
GLY A  84
VAL A  86
ALA A  99
MET A 147
LEU A 201
 ATP  A 535 (-3.9A)
ATP  A 535 ( 3.9A)
ATP  A 535 (-3.8A)
ATP  A 535 ( 4.4A)
ATP  A 535 (-4.1A)
ATP  A 535 (-3.6A)
ATP  A 535 ( 3.4A)
ATP  A 535 (-4.8A)
 0.77A 3fupA-1s9iA:
22.7		 3fupA-1s9iA:
28.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1u5q SERINE/THREONINE
PROTEIN KINASE TAO2

(Rattus
norvegicus) 		PF00069
(Pkinase) 		8 GLY A  35
VAL A  42
ALA A  55
LYS A  57
MET A 105
TYR A 107
SER A 111
LEU A 158
 None
 0.70A 3fupA-1u5qA:
25.5		 3fupA-1u5qA:
29.86
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2dq7 PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE FYN

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		8 LEU X  17
GLY X  18
GLY X  20
GLY X  23
VAL X  25
ALA X  37
TYR X  84
LEU X 137
 STU  X 902 (-3.8A)
STU  X 902 ( 3.7A)
None
None
STU  X 902 ( 4.8A)
STU  X 902 (-3.1A)
STU  X 902 (-4.6A)
STU  X 902 (-4.4A)
 0.69A 3fupA-2dq7X:
32.5		 3fupA-2dq7X:
32.67
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2dq7 PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE FYN

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		9 LEU X  17
GLY X  18
GLY X  20
VAL X  25
ALA X  37
TYR X  84
SER X  89
LEU X 137
ASP X 148
 STU  X 902 (-3.8A)
STU  X 902 ( 3.7A)
None
STU  X 902 ( 4.8A)
STU  X 902 (-3.1A)
STU  X 902 (-4.6A)
STU  X 902 ( 4.0A)
STU  X 902 (-4.4A)
STU  X 902 (-3.6A)
 1.13A 3fupA-2dq7X:
32.5		 3fupA-2dq7X:
32.67
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2dq7 PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE FYN

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		9 LEU X  17
GLY X  18
VAL X  25
ALA X  37
LYS X  39
TYR X  84
SER X  89
LEU X 137
ASP X 148
 STU  X 902 (-3.8A)
STU  X 902 ( 3.7A)
STU  X 902 ( 4.8A)
STU  X 902 (-3.1A)
STU  X 902 (-3.1A)
STU  X 902 (-4.6A)
STU  X 902 ( 4.0A)
STU  X 902 (-4.4A)
STU  X 902 (-3.6A)
 0.82A 3fupA-2dq7X:
32.5		 3fupA-2dq7X:
32.67
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2gcd SERINE/THREONINE-PRO
TEIN KINASE TAO2

(Rattus
norvegicus) 		PF00069
(Pkinase) 		8 GLY A  35
GLY A  37
GLY A  40
VAL A  42
ALA A  55
LYS A  57
MET A 105
TYR A 107
 STU  A 400 (-3.3A)
None
None
STU  A 400 ( 4.8A)
STU  A 400 (-3.2A)
STU  A 400 ( 4.5A)
STU  A 400 ( 3.7A)
STU  A 400 (-4.5A)
 0.78A 3fupA-2gcdA:
26.4		 3fupA-2gcdA:
30.41
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2gcd SERINE/THREONINE-PRO
TEIN KINASE TAO2

(Rattus
norvegicus) 		PF00069
(Pkinase) 		8 GLY A  35
VAL A  42
ALA A  55
LYS A  57
MET A 105
TYR A 107
SER A 111
LEU A 158
 STU  A 400 (-3.3A)
STU  A 400 ( 4.8A)
STU  A 400 (-3.2A)
STU  A 400 ( 4.5A)
STU  A 400 ( 3.7A)
STU  A 400 (-4.5A)
STU  A 400 (-3.3A)
STU  A 400 ( 4.6A)
 0.78A 3fupA-2gcdA:
26.4		 3fupA-2gcdA:
30.41
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2gcd SERINE/THREONINE-PRO
TEIN KINASE TAO2

(Rattus
norvegicus) 		PF00069
(Pkinase) 		8 GLY A  35
VAL A  42
ALA A  55
MET A 105
TYR A 107
SER A 111
LEU A 158
ASP A 169
 STU  A 400 (-3.3A)
STU  A 400 ( 4.8A)
STU  A 400 (-3.2A)
STU  A 400 ( 3.7A)
STU  A 400 (-4.5A)
STU  A 400 (-3.3A)
STU  A 400 ( 4.6A)
STU  A 400 (-3.6A)
 0.80A 3fupA-2gcdA:
26.4		 3fupA-2gcdA:
30.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2h8h PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE SRC

(Homo sapiens) 		PF00017
(SH2)
PF00018
(SH3_1)
PF07714
(Pkinase_Tyr) 		8 LEU A 273
GLY A 274
GLY A 276
GLY A 279
VAL A 281
ALA A 293
LYS A 295
TYR A 340
 H8H  A 534 (-3.8A)
H8H  A 534 ( 3.8A)
None
None
H8H  A 534 (-4.4A)
H8H  A 534 (-3.2A)
H8H  A 534 (-3.7A)
H8H  A 534 (-4.3A)
 0.81A 3fupA-2h8hA:
29.3		 3fupA-2h8hA:
22.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2h8h PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE SRC

(Homo sapiens) 		PF00017
(SH2)
PF00018
(SH3_1)
PF07714
(Pkinase_Tyr) 		8 LEU A 273
GLY A 274
GLY A 279
VAL A 281
ALA A 293
TYR A 340
SER A 345
LEU A 393
 H8H  A 534 (-3.8A)
H8H  A 534 ( 3.8A)
None
H8H  A 534 (-4.4A)
H8H  A 534 (-3.2A)
H8H  A 534 (-4.3A)
H8H  A 534 ( 4.5A)
H8H  A 534 (-4.5A)
 0.72A 3fupA-2h8hA:
29.3		 3fupA-2h8hA:
22.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2hck HEMATOPOETIC CELL
KINASE HCK

(Homo sapiens) 		PF00017
(SH2)
PF00018
(SH3_1)
PF07714
(Pkinase_Tyr) 		8 LEU A 273
GLY A 274
GLY A 276
GLY A 279
VAL A 281
ALA A 293
LYS A 295
LEU A 393
 QUE  A   1 (-3.9A)
QUE  A   1 ( 4.2A)
None
None
QUE  A   1 ( 4.8A)
QUE  A   1 (-3.5A)
None
QUE  A   1 (-4.4A)
 0.76A 3fupA-2hckA:
28.7		 3fupA-2hckA:
26.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2hck HEMATOPOETIC CELL
KINASE HCK

(Homo sapiens) 		PF00017
(SH2)
PF00018
(SH3_1)
PF07714
(Pkinase_Tyr) 		8 LEU A 273
GLY A 274
GLY A 276
GLY A 279
VAL A 281
ALA A 293
SER A 345
LEU A 393
 QUE  A   1 (-3.9A)
QUE  A   1 ( 4.2A)
None
None
QUE  A   1 ( 4.8A)
QUE  A   1 (-3.5A)
QUE  A   1 ( 4.7A)
QUE  A   1 (-4.4A)
 0.73A 3fupA-2hckA:
28.7		 3fupA-2hckA:
26.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2j0j FOCAL ADHESION
KINASE 1

(Gallus gallus) 		PF00373
(FERM_M)
PF07714
(Pkinase_Tyr) 		8 GLY A 429
GLY A 431
GLY A 434
VAL A 436
ALA A 452
LYS A 454
MET A 499
LEU A 553
 4ST  A1687 (-3.1A)
None
None
4ST  A1687 ( 4.8A)
4ST  A1687 (-3.3A)
4ST  A1687 (-3.4A)
4ST  A1687 ( 3.9A)
4ST  A1687 (-4.4A)
 0.82A 3fupA-2j0jA:
31.2		 3fupA-2j0jA:
19.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ozo TYROSINE-PROTEIN
KINASE ZAP-70

(Homo sapiens) 		PF00017
(SH2)
PF07714
(Pkinase_Tyr) 		8 LEU A 344
GLY A 345
GLY A 347
GLY A 350
VAL A 352
ALA A 367
LYS A 369
MET A 414
 ANP  A 615 (-4.4A)
ANP  A 615 ( 4.4A)
ANP  A 615 (-3.6A)
None
ANP  A 615 (-4.5A)
ANP  A 615 (-3.3A)
ANP  A 615 (-3.1A)
ANP  A 615 ( 3.9A)
 0.78A 3fupA-2ozoA:
21.9		 3fupA-2ozoA:
19.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ozo TYROSINE-PROTEIN
KINASE ZAP-70

(Homo sapiens) 		PF00017
(SH2)
PF07714
(Pkinase_Tyr) 		8 LEU A 344
GLY A 345
GLY A 347
GLY A 350
VAL A 352
ALA A 367
MET A 414
LEU A 468
 ANP  A 615 (-4.4A)
ANP  A 615 ( 4.4A)
ANP  A 615 (-3.6A)
None
ANP  A 615 (-4.5A)
ANP  A 615 (-3.3A)
ANP  A 615 ( 3.9A)
ANP  A 615 (-4.7A)
 0.82A 3fupA-2ozoA:
21.9		 3fupA-2ozoA:
19.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2wtk SERINE/THREONINE-PRO
TEIN KINASE 11

(Homo sapiens) 		PF00069
(Pkinase) 		8 GLY C  56
GLY C  58
GLY C  61
VAL C  63
ALA C  76
MET C 129
TYR C 131
LEU C 183
 ANP  C   2 (-3.3A)
ANP  C   2 (-3.0A)
ANP  C   2 (-3.8A)
ANP  C   2 (-4.2A)
ANP  C   2 (-3.4A)
None
None
None
 0.73A 3fupA-2wtkC:
25.2		 3fupA-2wtkC:
24.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2wtk SERINE/THREONINE-PRO
TEIN KINASE 11

(Homo sapiens) 		PF00069
(Pkinase) 		8 LEU C  55
GLY C  56
GLY C  58
GLY C  61
VAL C  63
ALA C  76
TYR C 131
LEU C 183
 ANP  C   2 ( 4.4A)
ANP  C   2 (-3.3A)
ANP  C   2 (-3.0A)
ANP  C   2 (-3.8A)
ANP  C   2 (-4.2A)
ANP  C   2 (-3.4A)
None
None
 0.62A 3fupA-2wtkC:
25.2		 3fupA-2wtkC:
24.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2wtk SERINE/THREONINE-PRO
TEIN KINASE 11

(Homo sapiens) 		PF00069
(Pkinase) 		8 LEU C  55
GLY C  56
GLY C  61
VAL C  63
ALA C  76
LYS C  78
TYR C 131
LEU C 183
 ANP  C   2 ( 4.4A)
ANP  C   2 (-3.3A)
ANP  C   2 (-3.8A)
ANP  C   2 (-4.2A)
ANP  C   2 (-3.4A)
ANP  C   2 (-3.6A)
None
None
 0.81A 3fupA-2wtkC:
25.2		 3fupA-2wtkC:
24.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2xik SERINE/THREONINE
PROTEIN KINASE 25

(Homo sapiens) 		PF00069
(Pkinase) 		9 GLY A  27
GLY A  32
VAL A  34
ALA A  47
LYS A  49
MET A  95
TYR A  97
SER A 102
LEU A 147
 J60  A1294 ( 4.1A)
None
J60  A1294 ( 4.9A)
J60  A1294 (-3.3A)
None
J60  A1294 ( 3.8A)
J60  A1294 (-4.5A)
None
J60  A1294 (-4.8A)
 0.89A 3fupA-2xikA:
27.6		 3fupA-2xikA:
30.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2xik SERINE/THREONINE
PROTEIN KINASE 25

(Homo sapiens) 		PF00069
(Pkinase) 		9 GLY A  27
GLY A  32
VAL A  34
ALA A  47
MET A  95
TYR A  97
SER A 102
LEU A 147
ASP A 158
 J60  A1294 ( 4.1A)
None
J60  A1294 ( 4.9A)
J60  A1294 (-3.3A)
J60  A1294 ( 3.8A)
J60  A1294 (-4.5A)
None
J60  A1294 (-4.8A)
J60  A1294 ( 4.6A)
 0.96A 3fupA-2xikA:
27.6		 3fupA-2xikA:
30.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2z7r RIBOSOMAL PROTEIN S6
KINASE ALPHA-1

(Homo sapiens) 		PF00069
(Pkinase) 		9 LEU A  68
GLY A  69
GLY A  71
GLY A  74
VAL A  76
ALA A  92
LYS A  94
LEU A 194
ASP A 205
 STU  A   1 (-3.8A)
STU  A   1 (-3.3A)
STU  A   1 ( 4.1A)
None
None
STU  A   1 (-3.3A)
STU  A   1 (-2.8A)
STU  A   1 (-4.6A)
STU  A   1 ( 3.8A)
 0.84A 3fupA-2z7rA:
22.6		 3fupA-2z7rA:
28.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3a62 RIBOSOMAL PROTEIN S6
KINASE BETA-1

(Homo sapiens) 		PF00069
(Pkinase) 		8 LEU A  97
GLY A  98
GLY A 100
GLY A 103
VAL A 105
ALA A 121
LYS A 123
TYR A 174
 STU  A 400 (-3.8A)
STU  A 400 (-3.6A)
None
None
STU  A 400 (-4.9A)
STU  A 400 (-3.1A)
STU  A 400 ( 4.3A)
STU  A 400 (-4.7A)
 0.38A 3fupA-3a62A:
22.7		 3fupA-3a62A:
26.45
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3b2t FIBROBLAST GROWTH
FACTOR RECEPTOR 2

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		9 LEU A 487
GLY A 488
GLY A 490
GLY A 493
VAL A 495
ALA A 515
LYS A 517
TYR A 566
LEU A 633
 M33  A1996 (-4.0A)
M33  A1996 ( 3.8A)
M33  A1996 (-3.0A)
None
M33  A1996 ( 4.7A)
M33  A1996 (-3.3A)
M33  A1996 ( 4.5A)
M33  A1996 ( 4.7A)
M33  A1996 (-4.5A)
 0.78A 3fupA-3b2tA:
27.0		 3fupA-3b2tA:
35.99
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3d7u TYROSINE-PROTEIN
KINASE CSK

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		8 GLY A 207
VAL A 209
ALA A 220
LYS A 222
TYR A 268
SER A 273
LEU A 321
ASP A 332
 None
 0.80A 3fupA-3d7uA:
32.4		 3fupA-3d7uA:
35.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3eb0 PUTATIVE
UNCHARACTERIZED
PROTEIN

(Cryptosporidium
parvum) 		PF00069
(Pkinase) 		8 LEU A  15
GLY A  16
GLY A  18
GLY A  21
VAL A  23
ALA A  36
MET A 117
TYR A 119
 DRK  A 384 (-3.8A)
DRK  A 384 ( 4.4A)
None
None
None
DRK  A 384 (-3.5A)
DRK  A 384 (-3.8A)
DRK  A 384 (-4.4A)
 0.73A 3fupA-3eb0A:
23.7		 3fupA-3eb0A:
26.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3eb0 PUTATIVE
UNCHARACTERIZED
PROTEIN

(Cryptosporidium
parvum) 		PF00069
(Pkinase) 		8 LEU A  15
GLY A  16
VAL A  23
ALA A  36
LYS A  38
MET A 117
TYR A 119
ASP A 185
 DRK  A 384 (-3.8A)
DRK  A 384 ( 4.4A)
None
DRK  A 384 (-3.5A)
None
DRK  A 384 (-3.8A)
DRK  A 384 (-4.4A)
DRK  A 384 ( 4.7A)
 0.75A 3fupA-3eb0A:
23.7		 3fupA-3eb0A:
26.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3f2a PROTO-ONCOGENE
SERINE/THREONINE-PRO
TEIN KINASE PIM-1

(Homo sapiens) 		PF00069
(Pkinase) 		8 LEU A  44
GLY A  45
GLY A  50
VAL A  52
ALA A  65
LYS A  67
LEU A 174
ASP A 186
 985  A   1 (-4.1A)
985  A   1 ( 3.9A)
None
985  A   1 (-4.5A)
985  A   1 (-3.5A)
985  A   1 ( 2.8A)
985  A   1 (-4.8A)
985  A   1 ( 4.0A)
 0.75A 3fupA-3f2aA:
17.3		 3fupA-3f2aA:
22.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3fme DUAL SPECIFICITY
MITOGEN-ACTIVATED
PROTEIN KINASE
KINASE 6

(Homo sapiens) 		PF00069
(Pkinase) 		9 LEU A  59
GLY A  60
GLY A  62
GLY A  65
VAL A  67
ALA A  80
MET A 129
SER A 135
LEU A 186
 STU  A   1 (-3.8A)
STU  A   1 (-3.5A)
None
None
None
STU  A   1 (-3.4A)
STU  A   1 ( 3.8A)
STU  A   1 (-3.2A)
STU  A   1 (-4.4A)
 0.70A 3fupA-3fmeA:
21.5		 3fupA-3fmeA:
26.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3fme DUAL SPECIFICITY
MITOGEN-ACTIVATED
PROTEIN KINASE
KINASE 6

(Homo sapiens) 		PF00069
(Pkinase) 		9 LEU A  59
GLY A  60
GLY A  65
VAL A  67
ALA A  80
LYS A  82
MET A 129
SER A 135
LEU A 186
 STU  A   1 (-3.8A)
STU  A   1 (-3.5A)
None
None
STU  A   1 (-3.4A)
STU  A   1 ( 4.2A)
STU  A   1 ( 3.8A)
STU  A   1 (-3.2A)
STU  A   1 (-4.4A)
 0.71A 3fupA-3fmeA:
21.5		 3fupA-3fmeA:
26.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3g2f BONE MORPHOGENETIC
PROTEIN RECEPTOR
TYPE-2

(Homo sapiens) 		PF00069
(Pkinase) 		9 GLY A 210
GLY A 212
GLY A 215
VAL A 217
ALA A 228
LYS A 230
MET A 279
TYR A 281
SER A 286
 ADP  A 900 (-3.4A)
ADP  A 900 (-3.0A)
ADP  A 900 (-3.7A)
ADP  A 900 (-4.3A)
ADP  A 900 (-3.4A)
ADP  A 900 (-2.8A)
ADP  A 900 (-3.6A)
None
ADP  A 900 (-3.6A)
 0.73A 3fupA-3g2fA:
21.2		 3fupA-3g2fA:
26.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3g2f BONE MORPHOGENETIC
PROTEIN RECEPTOR
TYPE-2

(Homo sapiens) 		PF00069
(Pkinase) 		8 GLY A 210
GLY A 212
VAL A 217
ALA A 228
MET A 279
TYR A 281
SER A 286
LEU A 340
 ADP  A 900 (-3.4A)
ADP  A 900 (-3.0A)
ADP  A 900 (-4.3A)
ADP  A 900 (-3.4A)
ADP  A 900 (-3.6A)
None
ADP  A 900 (-3.6A)
ADP  A 900 (-4.6A)
 0.77A 3fupA-3g2fA:
21.2		 3fupA-3g2fA:
26.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3hdn SERINE/THREONINE-PRO
TEIN KINASE SGK1

(Homo sapiens) 		PF00069
(Pkinase) 		8 GLY A 105
GLY A 107
GLY A 110
VAL A 112
ALA A 125
LYS A 127
TYR A 178
LEU A 229
 None
GMG  A   1 (-3.3A)
None
None
GMG  A   1 (-3.4A)
GMG  A   1 (-3.0A)
GMG  A   1 ( 4.9A)
GMG  A   1 ( 4.9A)
 0.73A 3fupA-3hdnA:
19.9		 3fupA-3hdnA:
25.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3hzt CALCIUM-DEPENDENT
PROTEIN KINASE 3

(Toxoplasma
gondii) 		PF00069
(Pkinase)
PF13499
(EF-hand_7) 		8 LEU A  82
GLY A  83
GLY A  88
VAL A  90
ALA A 103
LYS A 105
LEU A 206
ASP A 220
 J60  A 540 (-3.8A)
J60  A 540 ( 4.3A)
GOL  A 544 (-3.4A)
None
J60  A 540 (-3.6A)
GOL  A   1 (-2.7A)
GOL  A 542 ( 4.6A)
J60  A 540 ( 3.6A)
 0.77A 3fupA-3hztA:
19.6		 3fupA-3hztA:
21.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3hzt CALCIUM-DEPENDENT
PROTEIN KINASE 3

(Toxoplasma
gondii) 		PF00069
(Pkinase)
PF13499
(EF-hand_7) 		8 LEU A  82
GLY A  83
GLY A  88
VAL A  90
ALA A 103
LYS A 105
MET A 153
ASP A 220
 J60  A 540 (-3.8A)
J60  A 540 ( 4.3A)
GOL  A 544 (-3.4A)
None
J60  A 540 (-3.6A)
GOL  A   1 (-2.7A)
GOL  A   1 ( 3.0A)
J60  A 540 ( 3.6A)
 0.52A 3fupA-3hztA:
19.6		 3fupA-3hztA:
21.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3igo CALMODULIN-DOMAIN
PROTEIN KINASE 1

(Cryptosporidium
parvum) 		PF00069
(Pkinase)
PF13499
(EF-hand_7) 		8 LEU A  82
GLY A  83
GLY A  85
GLY A  88
VAL A  90
ALA A 103
LYS A 105
LEU A 205
 ANP  A 610 ( 4.5A)
ANP  A 610 (-3.5A)
ANP  A 610 (-2.9A)
ANP  A 610 (-4.5A)
ANP  A 610 (-3.9A)
ANP  A 610 ( 3.7A)
ANP  A 610 (-2.8A)
None
 0.78A 3fupA-3igoA:
19.6		 3fupA-3igoA:
20.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3mdy BONE MORPHOGENETIC
PROTEIN RECEPTOR
TYPE-1B

(Homo sapiens) 		PF07714
(Pkinase_Tyr)
PF08515
(TGF_beta_GS) 		8 GLY A 211
GLY A 216
VAL A 218
ALA A 229
LYS A 231
TYR A 281
SER A 286
ASP A 350
 LDN  A   1 ( 4.7A)
None
LDN  A   1 ( 4.8A)
LDN  A   1 (-3.6A)
None
LDN  A   1 ( 4.8A)
None
LDN  A   1 (-3.9A)
 0.73A 3fupA-3mdyA:
28.0		 3fupA-3mdyA:
28.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3mdy BONE MORPHOGENETIC
PROTEIN RECEPTOR
TYPE-1B

(Homo sapiens) 		PF07714
(Pkinase_Tyr)
PF08515
(TGF_beta_GS) 		8 GLY A 211
GLY A 216
VAL A 218
ALA A 229
LYS A 231
TYR A 281
SER A 286
LEU A 339
 LDN  A   1 ( 4.7A)
None
LDN  A   1 ( 4.8A)
LDN  A   1 (-3.6A)
None
LDN  A   1 ( 4.8A)
None
LDN  A   1 (-4.5A)
 0.72A 3fupA-3mdyA:
28.0		 3fupA-3mdyA:
28.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3mvj CAMP-DEPENDENT
PROTEIN KINASE
CATALYTIC SUBUNIT
ALPHA

(Homo sapiens) 		PF00069
(Pkinase) 		10 LEU A  49
GLY A  50
GLY A  52
GLY A  55
VAL A  57
ALA A  70
MET A 120
TYR A 122
LEU A 173
ASP A 184
 XFE  A 351 (-4.2A)
XFE  A 351 ( 4.0A)
None
None
XFE  A 351 ( 4.5A)
XFE  A 351 (-3.2A)
XFE  A 351 ( 4.0A)
None
XFE  A 351 (-4.6A)
None
 0.80A 3fupA-3mvjA:
24.6		 3fupA-3mvjA:
23.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3mvj CAMP-DEPENDENT
PROTEIN KINASE
CATALYTIC SUBUNIT
ALPHA

(Homo sapiens) 		PF00069
(Pkinase) 		10 LEU A  49
GLY A  50
GLY A  55
VAL A  57
ALA A  70
LYS A  72
MET A 120
TYR A 122
LEU A 173
ASP A 184
 XFE  A 351 (-4.2A)
XFE  A 351 ( 4.0A)
None
XFE  A 351 ( 4.5A)
XFE  A 351 (-3.2A)
None
XFE  A 351 ( 4.0A)
None
XFE  A 351 (-4.6A)
None
 0.75A 3fupA-3mvjA:
24.6		 3fupA-3mvjA:
23.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3nuu PKB-LIKE

(Homo sapiens) 		PF00069
(Pkinase) 		8 LEU A  88
GLY A  89
GLY A  91
VAL A  96
ALA A 109
LYS A 111
TYR A 161
LEU A 212
 JOZ  A 361 (-4.1A)
JOZ  A 361 ( 4.3A)
SO4  A   5 ( 4.4A)
JOZ  A 361 ( 4.7A)
JOZ  A 361 (-3.4A)
SO4  A   5 (-2.8A)
None
None
 0.78A 3fupA-3nuuA:
25.2		 3fupA-3nuuA:
25.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3pfq PROTEIN KINASE C
BETA TYPE

(Rattus
norvegicus) 		PF00069
(Pkinase)
PF00130
(C1_1)
PF00168
(C2)
PF00433
(Pkinase_C) 		8 LEU A 348
GLY A 349
GLY A 354
VAL A 356
ALA A 369
LYS A 371
MET A 420
TYR A 422
 ANP  A 800 ( 4.4A)
ANP  A 800 ( 4.3A)
None
ANP  A 800 ( 4.7A)
ANP  A 800 (-3.6A)
ANP  A 800 (-3.3A)
ANP  A 800 (-4.8A)
ANP  A 800 (-4.2A)
 0.64A 3fupA-3pfqA:
22.0		 3fupA-3pfqA:
17.07
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3pp0 RECEPTOR
TYROSINE-PROTEIN
KINASE ERBB-2

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		8 LEU A 726
GLY A 727
GLY A 732
VAL A 734
ALA A 751
LYS A 753
LEU A 852
ASP A 863
 03Q  A   1 (-3.8A)
None
None
03Q  A   1 (-4.5A)
03Q  A   1 (-3.1A)
03Q  A   1 (-4.7A)
03Q  A   1 (-4.4A)
03Q  A   1 (-4.0A)
 0.54A 3fupA-3pp0A:
34.5		 3fupA-3pp0A:
32.01
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3ppz SERINE/THREONINE-PRO
TEIN KINASE CTR1

(Arabidopsis
thaliana) 		PF07714
(Pkinase_Tyr) 		8 GLY A 558
GLY A 560
GLY A 563
VAL A 565
ALA A 576
TYR A 627
SER A 632
LEU A 683
 STU  A   1 (-3.2A)
None
None
STU  A   1 (-4.9A)
STU  A   1 (-3.3A)
STU  A   1 (-4.4A)
STU  A   1 ( 4.3A)
STU  A   1 (-4.3A)
 0.77A 3fupA-3ppzA:
29.9		 3fupA-3ppzA:
30.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3qa8 MGC80376 PROTEIN

(Xenopus laevis) 		PF00069
(Pkinase) 		9 LEU A  21
GLY A  22
GLY A  24
GLY A  27
VAL A  29
ALA A  42
LYS A  44
MET A  96
TYR A  98
 None
 0.73A 3fupA-3qa8A:
20.2		 3fupA-3qa8A:
19.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3qfv CDC42BPB PROTEIN

(Homo sapiens) 		PF00069
(Pkinase) 		8 GLY A  83
GLY A  85
GLY A  88
VAL A  90
ALA A 103
LYS A 105
MET A 153
TYR A 155
 NM7  A 416 (-3.0A)
None
None
NM7  A 416 (-3.7A)
NM7  A 416 ( 3.7A)
EDO  A 417 (-3.5A)
NM7  A 416 (-3.6A)
NM7  A 416 (-4.4A)
 0.71A 3fupA-3qfvA:
22.4		 3fupA-3qfvA:
22.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3qfv CDC42BPB PROTEIN

(Homo sapiens) 		PF00069
(Pkinase) 		8 GLY A  83
GLY A  85
GLY A  88
VAL A  90
ALA A 103
LYS A 105
TYR A 155
ASP A 218
 NM7  A 416 (-3.0A)
None
None
NM7  A 416 (-3.7A)
NM7  A 416 ( 3.7A)
EDO  A 417 (-3.5A)
NM7  A 416 (-4.4A)
EDO  A 417 (-3.7A)
 0.72A 3fupA-3qfvA:
22.4		 3fupA-3qfvA:
22.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3qfv CDC42BPB PROTEIN

(Homo sapiens) 		PF00069
(Pkinase) 		8 GLY A  83
GLY A  85
VAL A  90
ALA A 103
LYS A 105
MET A 153
TYR A 155
LEU A 207
 NM7  A 416 (-3.0A)
None
NM7  A 416 (-3.7A)
NM7  A 416 ( 3.7A)
EDO  A 417 (-3.5A)
NM7  A 416 (-3.6A)
NM7  A 416 (-4.4A)
NM7  A 416 ( 4.2A)
 0.74A 3fupA-3qfvA:
22.4		 3fupA-3qfvA:
22.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3qfv CDC42BPB PROTEIN

(Homo sapiens) 		PF00069
(Pkinase) 		8 GLY A  83
GLY A  85
VAL A  90
ALA A 103
LYS A 105
TYR A 155
LEU A 207
ASP A 218
 NM7  A 416 (-3.0A)
None
NM7  A 416 (-3.7A)
NM7  A 416 ( 3.7A)
EDO  A 417 (-3.5A)
NM7  A 416 (-4.4A)
NM7  A 416 ( 4.2A)
EDO  A 417 (-3.7A)
 0.70A 3fupA-3qfvA:
22.4		 3fupA-3qfvA:
22.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3she MAP KINASE-ACTIVATED
PROTEIN KINASE 3

(Homo sapiens) 		PF00069
(Pkinase) 		9 LEU A  50
GLY A  51
GLY A  53
GLY A  56
VAL A  58
ALA A  71
LYS A  73
LEU A 173
ASP A 187
 I85  A 350 (-3.7A)
I85  A 350 (-3.5A)
I85  A 350 (-3.1A)
None
I85  A 350 (-4.9A)
I85  A 350 (-3.3A)
I85  A 350 (-2.8A)
None
I85  A 350 (-3.3A)
 0.99A 3fupA-3sheA:
20.3		 3fupA-3sheA:
26.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3she MAP KINASE-ACTIVATED
PROTEIN KINASE 3

(Homo sapiens) 		PF00069
(Pkinase) 		9 LEU A  50
GLY A  51
GLY A  56
VAL A  58
ALA A  71
LYS A  73
MET A 118
LEU A 173
ASP A 187
 I85  A 350 (-3.7A)
I85  A 350 (-3.5A)
None
I85  A 350 (-4.9A)
I85  A 350 (-3.3A)
I85  A 350 (-2.8A)
I85  A 350 ( 3.9A)
None
I85  A 350 (-3.3A)
 0.83A 3fupA-3sheA:
20.3		 3fupA-3sheA:
26.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3tt0 BASIC FIBROBLAST
GROWTH FACTOR
RECEPTOR 1

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		9 LEU A 484
GLY A 485
GLY A 487
GLY A 490
VAL A 492
ALA A 512
LYS A 514
TYR A 563
LEU A 630
 07J  A   1 ( 4.3A)
07J  A   1 ( 4.9A)
None
None
07J  A   1 (-4.0A)
07J  A   1 (-3.5A)
07J  A   1 (-4.5A)
07J  A   1 (-4.7A)
07J  A   1 ( 4.4A)
 0.62A 3fupA-3tt0A:
28.6		 3fupA-3tt0A:
35.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4aw2 SERINE/THREONINE-PRO
TEIN KINASE MRCK
ALPHA

(Rattus
norvegicus) 		PF00069
(Pkinase)
PF00433
(Pkinase_C) 		8 GLY A  84
VAL A  91
ALA A 104
LYS A 106
MET A 154
TYR A 156
LEU A 208
ASP A 219
 None
None
EDO  A1420 (-3.4A)
EDO  A1419 (-3.3A)
None
EDO  A1420 (-4.9A)
EDO  A1420 ( 4.8A)
None
 0.69A 3fupA-4aw2A:
22.7		 3fupA-4aw2A:
21.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4cfh 5'-AMP-ACTIVATED
PROTEIN KINASE
CATALYTIC SUBUNIT
ALPHA-1

(Rattus
norvegicus) 		PF00069
(Pkinase)
PF16579
(AdenylateSensor) 		9 GLY A  23
GLY A  28
VAL A  30
ALA A  43
LYS A  45
MET A  93
TYR A  95
LEU A 146
ASP A 157
 STU  A1550 (-3.1A)
None
None
STU  A1550 (-3.1A)
STU  A1550 (-3.6A)
STU  A1550 (-3.7A)
STU  A1550 (-4.5A)
STU  A1550 (-4.3A)
STU  A1550 (-3.6A)
 0.90A 3fupA-4cfhA:
26.2		 3fupA-4cfhA:
23.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4cfh 5'-AMP-ACTIVATED
PROTEIN KINASE
CATALYTIC SUBUNIT
ALPHA-1

(Rattus
norvegicus) 		PF00069
(Pkinase)
PF16579
(AdenylateSensor) 		9 LEU A  22
GLY A  23
GLY A  28
VAL A  30
ALA A  43
LYS A  45
MET A  93
TYR A  95
LEU A 146
 STU  A1550 (-4.3A)
STU  A1550 (-3.1A)
None
None
STU  A1550 (-3.1A)
STU  A1550 (-3.6A)
STU  A1550 (-3.7A)
STU  A1550 (-4.5A)
STU  A1550 (-4.3A)
 0.93A 3fupA-4cfhA:
26.2		 3fupA-4cfhA:
23.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4crs SERINE/THREONINE-PRO
TEIN KINASE N2

(Homo sapiens) 		PF00069
(Pkinase)
PF00433
(Pkinase_C) 		8 LEU A 663
GLY A 666
GLY A 669
VAL A 671
ALA A 684
MET A 737
TYR A 739
LEU A 789
 AGS  A1985 (-4.2A)
AGS  A1985 (-2.9A)
AGS  A1985 (-4.1A)
AGS  A1985 (-4.6A)
AGS  A1985 (-3.5A)
AGS  A1985 (-4.2A)
None
AGS  A1985 (-4.8A)
 0.59A 3fupA-4crsA:
11.5		 3fupA-4crsA:
25.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4crs SERINE/THREONINE-PRO
TEIN KINASE N2

(Homo sapiens) 		PF00069
(Pkinase)
PF00433
(Pkinase_C) 		8 LEU A 663
GLY A 669
VAL A 671
ALA A 684
LYS A 686
MET A 737
TYR A 739
LEU A 789
 AGS  A1985 (-4.2A)
AGS  A1985 (-4.1A)
AGS  A1985 (-4.6A)
AGS  A1985 (-3.5A)
AGS  A1985 (-3.0A)
AGS  A1985 (-4.2A)
None
AGS  A1985 (-4.8A)
 0.69A 3fupA-4crsA:
11.5		 3fupA-4crsA:
25.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4euu SERINE/THREONINE-PRO
TEIN KINASE TBK1

(Homo sapiens) 		PF00069
(Pkinase) 		8 LEU A  15
GLY A  16
VAL A  23
ALA A  36
LYS A  38
MET A  86
SER A  93
ASP A 157
 BX7  A 401 (-3.9A)
BX7  A 401 ( 3.8A)
BX7  A 401 ( 4.6A)
BX7  A 401 (-3.4A)
BX7  A 401 (-3.5A)
BX7  A 401 (-3.7A)
BX7  A 401 ( 4.7A)
BX7  A 401 (-3.6A)
 0.74A 3fupA-4euuA:
14.4		 3fupA-4euuA:
26.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4fl3 TYROSINE-PROTEIN
KINASE SYK

(Homo sapiens) 		PF00017
(SH2)
PF07714
(Pkinase_Tyr) 		8 LEU A 377
GLY A 378
GLY A 380
GLY A 383
VAL A 385
ALA A 400
LYS A 402
MET A 448
 ANP  A 701 ( 4.6A)
ANP  A 701 ( 4.0A)
ANP  A 701 (-3.5A)
None
ANP  A 701 (-4.1A)
ANP  A 701 (-3.3A)
ANP  A 701 (-2.7A)
ANP  A 701 ( 3.7A)
 0.52A 3fupA-4fl3A:
29.0		 3fupA-4fl3A:
19.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4fl3 TYROSINE-PROTEIN
KINASE SYK

(Homo sapiens) 		PF00017
(SH2)
PF07714
(Pkinase_Tyr) 		8 LEU A 377
GLY A 378
GLY A 380
GLY A 383
VAL A 385
ALA A 400
MET A 448
LEU A 501
 ANP  A 701 ( 4.6A)
ANP  A 701 ( 4.0A)
ANP  A 701 (-3.5A)
None
ANP  A 701 (-4.1A)
ANP  A 701 (-3.3A)
ANP  A 701 ( 3.7A)
ANP  A 701 (-4.5A)
 0.65A 3fupA-4fl3A:
29.0		 3fupA-4fl3A:
19.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4g3f NF-KAPPA-BETA-INDUCI
NG KINASE

(Mus musculus) 		PF00069
(Pkinase) 		8 GLY A 409
GLY A 414
VAL A 416
ALA A 429
LYS A 431
SER A 478
LEU A 524
ASP A 536
 0WB  A 701 ( 4.4A)
None
0WB  A 701 (-4.4A)
0WB  A 701 (-3.3A)
0WB  A 701 (-3.0A)
0WB  A 701 ( 4.4A)
0WB  A 701 (-4.3A)
0WB  A 701 (-3.1A)
 0.73A 3fupA-4g3fA:
25.1		 3fupA-4g3fA:
25.90
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4gl9 TYROSINE-PROTEIN
KINASE

(Mus musculus) 		PF07714
(Pkinase_Tyr) 		11 LEU A 855
GLY A 856
GLY A 858
GLY A 861
VAL A 863
ALA A 880
LYS A 882
MET A 929
TYR A 931
SER A 936
ASP A 994
 IZA  A2001 (-3.7A)
IZA  A2001 ( 4.9A)
IZA  A2001 ( 3.7A)
None
None
IZA  A2001 (-3.4A)
IZA  A2001 ( 4.7A)
IZA  A2001 (-4.4A)
None
None
IZA  A2001 ( 4.5A)
 0.64A 3fupA-4gl9A:
41.7		 3fupA-4gl9A:
96.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4gl9 TYROSINE-PROTEIN
KINASE

(Mus musculus) 		PF07714
(Pkinase_Tyr) 		11 LEU A 855
GLY A 856
GLY A 861
VAL A 863
ALA A 880
LYS A 882
MET A 929
TYR A 931
SER A 936
LEU A 983
ASP A 994
 IZA  A2001 (-3.7A)
IZA  A2001 ( 4.9A)
None
None
IZA  A2001 (-3.4A)
IZA  A2001 ( 4.7A)
IZA  A2001 (-4.4A)
None
None
IZA  A2001 ( 4.7A)
IZA  A2001 ( 4.5A)
 0.67A 3fupA-4gl9A:
41.7		 3fupA-4gl9A:
96.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4hvi TYROSINE-PROTEIN
KINASE JAK3

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		10 LEU A 828
GLY A 829
GLY A 831
GLY A 834
VAL A 836
ALA A 853
LYS A 855
MET A 902
TYR A 904
LEU A 956
 19S  A1201 (-3.9A)
19S  A1201 (-3.7A)
19S  A1201 ( 4.3A)
19S  A1201 ( 4.9A)
19S  A1201 (-4.4A)
19S  A1201 (-3.3A)
19S  A1201 (-3.5A)
19S  A1201 (-3.6A)
19S  A1201 (-4.7A)
19S  A1201 (-4.5A)
 0.64A 3fupA-4hviA:
40.3		 3fupA-4hviA:
61.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4idt MITOGEN-ACTIVATED
PROTEIN KINASE
KINASE KINASE 14

(Homo sapiens) 		PF00069
(Pkinase) 		10 LEU A 406
GLY A 407
GLY A 412
VAL A 414
ALA A 427
LYS A 429
MET A 469
SER A 476
LEU A 522
ASP A 534
 T28  A 701 (-3.8A)
T28  A 701 ( 3.6A)
None
T28  A 701 (-4.7A)
T28  A 701 (-3.0A)
T28  A 701 ( 3.8A)
T28  A 701 (-2.6A)
T28  A 701 (-3.8A)
T28  A 701 (-3.9A)
T28  A 701 ( 3.4A)
 0.81A 3fupA-4idtA:
25.4		 3fupA-4idtA:
26.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4k11 PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE SRC

(Homo sapiens) 		PF00017
(SH2)
PF00018
(SH3_1)
PF07714
(Pkinase_Tyr) 		8 LEU A 273
GLY A 274
GLY A 276
GLY A 279
VAL A 281
ALA A 293
LYS A 295
TYR A 340
 0J9  A 601 (-4.0A)
0J9  A 601 ( 4.0A)
None
None
0J9  A 601 (-4.4A)
0J9  A 601 (-3.3A)
0J9  A 601 ( 4.7A)
0J9  A 601 ( 4.7A)
 0.67A 3fupA-4k11A:
29.2		 3fupA-4k11A:
24.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4k11 PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE SRC

(Homo sapiens) 		PF00017
(SH2)
PF00018
(SH3_1)
PF07714
(Pkinase_Tyr) 		9 LEU A 273
GLY A 274
GLY A 276
GLY A 279
VAL A 281
ALA A 293
TYR A 340
SER A 345
LEU A 393
 0J9  A 601 (-4.0A)
0J9  A 601 ( 4.0A)
None
None
0J9  A 601 (-4.4A)
0J9  A 601 (-3.3A)
0J9  A 601 ( 4.7A)
0J9  A 601 (-4.5A)
0J9  A 601 (-4.5A)
 0.73A 3fupA-4k11A:
29.2		 3fupA-4k11A:
24.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4k33 FIBROBLAST GROWTH
FACTOR RECEPTOR 3

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		8 LEU A 478
GLY A 479
GLY A 481
GLY A 484
VAL A 486
ALA A 506
TYR A 557
LEU A 624
 ACP  A 801 (-3.8A)
ACP  A 801 (-3.4A)
ACP  A 801 (-3.6A)
ACP  A 801 (-3.6A)
ACP  A 801 (-4.2A)
ACP  A 801 (-3.3A)
None
ACP  A 801 (-4.4A)
 0.74A 3fupA-4k33A:
28.1		 3fupA-4k33A:
35.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ks8 SERINE/THREONINE-PRO
TEIN KINASE PAK 6

(Homo sapiens) 		PF00069
(Pkinase) 		8 GLY A 414
GLY A 416
GLY A 419
VAL A 421
ALA A 434
LYS A 436
MET A 481
LEU A 533
 B49  A 701 ( 4.3A)
None
None
None
B49  A 701 (-3.2A)
None
B49  A 701 (-3.4A)
B49  A 701 (-4.5A)
 0.65A 3fupA-4ks8A:
26.7		 3fupA-4ks8A:
26.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4l52 MITOGEN-ACTIVATED
PROTEIN KINASE
KINASE KINASE 7,
TGF-BETA-ACTIVATED
KINASE 1 AND
MAP3K7-BINDING
PROTEIN 1 CHIMERA

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		9 GLY A  43
GLY A  45
GLY A  48
VAL A  50
ALA A  61
LYS A  63
MET A 104
TYR A 106
SER A 111
 1UL  A 501 ( 4.1A)
1UL  A 501 ( 3.7A)
None
1UL  A 501 ( 4.9A)
1UL  A 501 (-3.1A)
None
1UL  A 501 (-3.6A)
1UL  A 501 (-4.1A)
None
 0.74A 3fupA-4l52A:
27.3		 3fupA-4l52A:
28.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4l52 MITOGEN-ACTIVATED
PROTEIN KINASE
KINASE KINASE 7,
TGF-BETA-ACTIVATED
KINASE 1 AND
MAP3K7-BINDING
PROTEIN 1 CHIMERA

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		9 GLY A  43
GLY A  48
VAL A  50
ALA A  61
LYS A  63
MET A 104
TYR A 106
SER A 111
LEU A 163
 1UL  A 501 ( 4.1A)
None
1UL  A 501 ( 4.9A)
1UL  A 501 (-3.1A)
None
1UL  A 501 (-3.6A)
1UL  A 501 (-4.1A)
None
1UL  A 501 (-4.3A)
 0.65A 3fupA-4l52A:
27.3		 3fupA-4l52A:
28.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4lgg PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE SRC

(Gallus gallus) 		PF07714
(Pkinase_Tyr) 		8 LEU A 273
GLY A 274
GLY A 279
VAL A 281
ALA A 293
TYR A 340
SER A 345
LEU A 393
 VGG  A 601 (-3.2A)
VGG  A 601 ( 3.8A)
None
VGG  A 601 ( 3.5A)
VGG  A 601 (-3.5A)
VGG  A 601 ( 4.0A)
VGG  A 601 ( 4.4A)
VGG  A 601 (-4.5A)
 0.78A 3fupA-4lggA:
27.9		 3fupA-4lggA:
32.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4o27 SERINE/THREONINE-PRO
TEIN KINASE 24

(Homo sapiens) 		PF00069
(Pkinase) 		9 GLY B  31
GLY B  33
GLY B  36
VAL B  38
ALA B  51
LYS B  53
MET B  99
TYR B 101
LEU B 151
 ADP  B 500 ( 3.8A)
ADP  B 500 (-3.3A)
None
ADP  B 500 (-4.5A)
ADP  B 500 (-3.3A)
ADP  B 500 (-3.1A)
ADP  B 500 ( 4.1A)
ADP  B 500 ( 4.7A)
ADP  B 500 (-4.7A)
 0.75A 3fupA-4o27B:
27.7		 3fupA-4o27B:
30.22
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4o27 SERINE/THREONINE-PRO
TEIN KINASE 24

(Homo sapiens) 		PF00069
(Pkinase) 		8 GLY B  31
GLY B  33
VAL B  38
ALA B  51
LYS B  53
MET B  99
TYR B 101
SER B 106
 ADP  B 500 ( 3.8A)
ADP  B 500 (-3.3A)
ADP  B 500 (-4.5A)
ADP  B 500 (-3.3A)
ADP  B 500 (-3.1A)
ADP  B 500 ( 4.1A)
ADP  B 500 ( 4.7A)
ADP  B 500 (-3.4A)
 0.79A 3fupA-4o27B:
27.7		 3fupA-4o27B:
30.22
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4oli NON-RECEPTOR
TYROSINE-PROTEIN
KINASE TYK2

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		10 LEU A 903
GLY A 904
GLY A 906
GLY A 909
VAL A 911
ALA A 928
LYS A 930
MET A 978
TYR A 980
SER A 985
 2TT  A1202 (-3.5A)
2TT  A1202 ( 4.2A)
2TT  A1202 ( 3.8A)
None
2TT  A1202 (-4.5A)
2TT  A1202 ( 3.9A)
None
2TT  A1202 ( 4.4A)
2TT  A1202 (-4.6A)
None
 0.65A 3fupA-4oliA:
38.7		 3fupA-4oliA:
50.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4oli NON-RECEPTOR
TYROSINE-PROTEIN
KINASE TYK2

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		10 LEU A 903
GLY A 904
GLY A 909
VAL A 911
ALA A 928
LYS A 930
MET A 978
TYR A 980
SER A 985
LEU A1030
 2TT  A1202 (-3.5A)
2TT  A1202 ( 4.2A)
None
2TT  A1202 (-4.5A)
2TT  A1202 ( 3.9A)
None
2TT  A1202 ( 4.4A)
2TT  A1202 (-4.6A)
None
2TT  A1202 (-4.4A)
 0.62A 3fupA-4oliA:
38.7		 3fupA-4oliA:
50.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4oli NON-RECEPTOR
TYROSINE-PROTEIN
KINASE TYK2

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		8 LEU A 903
GLY A 904
GLY A 909
VAL A 911
TYR A 980
SER A 985
LEU A1030
ASP A1041
 2TT  A1202 (-3.5A)
2TT  A1202 ( 4.2A)
None
2TT  A1202 (-4.5A)
2TT  A1202 (-4.6A)
None
2TT  A1202 (-4.4A)
2TT  A1202 (-4.6A)
 0.79A 3fupA-4oliA:
38.7		 3fupA-4oliA:
50.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4red 5'-AMP-ACTIVATED
PROTEIN KINASE
CATALYTIC SUBUNIT
ALPHA-1

(Homo sapiens) 		PF00069
(Pkinase) 		9 LEU A  24
GLY A  25
GLY A  27
GLY A  30
VAL A  32
ALA A  45
LYS A  47
MET A  95
TYR A  97
 None
 0.80A 3fupA-4redA:
16.9		 3fupA-4redA:
26.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4rew 5'-AMP-ACTIVATED
PROTEIN KINASE
CATALYTIC SUBUNIT
ALPHA-1

(Homo sapiens) 		PF00069
(Pkinase)
PF16579
(AdenylateSensor) 		10 LEU A  24
GLY A  25
GLY A  30
VAL A  32
ALA A  45
LYS A  47
MET A  95
TYR A  97
LEU A 148
ASP A 159
 STU  A 601 (-3.7A)
STU  A 601 (-3.5A)
None
STU  A 601 ( 4.8A)
STU  A 601 (-3.2A)
STU  A 601 ( 3.7A)
STU  A 601 (-4.3A)
STU  A 601 (-4.4A)
STU  A 601 (-4.2A)
STU  A 601 (-3.7A)
 0.70A 3fupA-4rewA:
26.0		 3fupA-4rewA:
19.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4wb7 DNAJ HOMOLOG
SUBFAMILY B MEMBER
1,CAMP-DEPENDENT
PROTEIN KINASE
CATALYTIC SUBUNIT
ALPHA

(Homo sapiens) 		PF00069
(Pkinase)
PF00226
(DnaJ) 		10 GLY A 105
GLY A 107
GLY A 110
VAL A 112
ALA A 125
LYS A 127
MET A 175
TYR A 177
LEU A 228
ASP A 239
 ATP  A 501 (-3.5A)
ATP  A 501 (-3.2A)
ATP  A 501 (-3.8A)
ATP  A 501 (-4.0A)
ATP  A 501 (-3.4A)
ATP  A 501 (-2.6A)
ATP  A 501 (-3.6A)
None
ATP  A 501 (-4.5A)
ZN  A 503 (-1.9A)
 0.78A 3fupA-4wb7A:
24.7		 3fupA-4wb7A:
23.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4wb7 DNAJ HOMOLOG
SUBFAMILY B MEMBER
1,CAMP-DEPENDENT
PROTEIN KINASE
CATALYTIC SUBUNIT
ALPHA

(Homo sapiens) 		PF00069
(Pkinase)
PF00226
(DnaJ) 		10 LEU A 104
GLY A 105
GLY A 107
GLY A 110
VAL A 112
ALA A 125
LYS A 127
MET A 175
TYR A 177
LEU A 228
 ATP  A 501 ( 4.3A)
ATP  A 501 (-3.5A)
ATP  A 501 (-3.2A)
ATP  A 501 (-3.8A)
ATP  A 501 (-4.0A)
ATP  A 501 (-3.4A)
ATP  A 501 (-2.6A)
ATP  A 501 (-3.6A)
None
ATP  A 501 (-4.5A)
 0.55A 3fupA-4wb7A:
24.7		 3fupA-4wb7A:
23.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4yff SERINE/THREONINE-PRO
TEIN KINASE TNNI3K

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		8 GLY A 470
VAL A 477
ALA A 488
LYS A 490
TYR A 541
SER A 546
LEU A 595
ASP A 606
 4CV  A 801 ( 3.9A)
None
4CV  A 801 (-3.5A)
4CV  A 801 (-3.9A)
4CV  A 801 (-3.9A)
None
4CV  A 801 (-4.4A)
4CV  A 801 (-3.5A)
 0.79A 3fupA-4yffA:
17.3		 3fupA-4yffA:
26.05
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5f1z NON-RECEPTOR
TYROSINE-PROTEIN
KINASE TYK2

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		11 LEU A 903
GLY A 904
GLY A 909
VAL A 911
ALA A 928
LYS A 930
MET A 978
TYR A 980
SER A 985
LEU A1030
ASP A1041
 5U3  A1200 (-3.8A)
5U3  A1200 ( 3.7A)
None
5U3  A1200 ( 4.4A)
5U3  A1200 (-3.5A)
None
5U3  A1200 ( 4.0A)
5U3  A1200 (-4.5A)
None
5U3  A1200 (-4.4A)
5U3  A1200 ( 4.9A)
 0.60A 3fupA-5f1zA:
39.1		 3fupA-5f1zA:
50.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5iso 5'-AMP-ACTIVATED
PROTEIN KINASE
CATALYTIC SUBUNIT
ALPHA-2

(Homo sapiens) 		PF00069
(Pkinase)
PF16579
(AdenylateSensor) 		9 LEU A  22
GLY A  23
GLY A  25
GLY A  28
VAL A  30
ALA A  43
LYS A  45
MET A  93
TYR A  95
 STU  A 601 (-4.1A)
STU  A 601 (-3.4A)
STU  A 601 (-3.7A)
992  A 602 ( 3.8A)
STU  A 601 (-4.8A)
STU  A 601 (-3.3A)
STU  A 601 ( 4.4A)
STU  A 601 ( 3.9A)
STU  A 601 (-4.3A)
 0.73A 3fupA-5isoA:
26.1		 3fupA-5isoA:
22.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5iso 5'-AMP-ACTIVATED
PROTEIN KINASE
CATALYTIC SUBUNIT
ALPHA-2

(Homo sapiens) 		PF00069
(Pkinase)
PF16579
(AdenylateSensor) 		9 LEU A  22
GLY A  23
GLY A  25
GLY A  28
VAL A  30
ALA A  43
MET A  93
TYR A  95
ASP A 157
 STU  A 601 (-4.1A)
STU  A 601 (-3.4A)
STU  A 601 (-3.7A)
992  A 602 ( 3.8A)
STU  A 601 (-4.8A)
STU  A 601 (-3.3A)
STU  A 601 ( 3.9A)
STU  A 601 (-4.3A)
STU  A 601 (-3.5A)
 0.79A 3fupA-5isoA:
26.1		 3fupA-5isoA:
22.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5iso 5'-AMP-ACTIVATED
PROTEIN KINASE
CATALYTIC SUBUNIT
ALPHA-2

(Homo sapiens) 		PF00069
(Pkinase)
PF16579
(AdenylateSensor) 		9 LEU A  22
GLY A  23
GLY A  28
VAL A  30
ALA A  43
LYS A  45
MET A  93
TYR A  95
LEU A 146
 STU  A 601 (-4.1A)
STU  A 601 (-3.4A)
992  A 602 ( 3.8A)
STU  A 601 (-4.8A)
STU  A 601 (-3.3A)
STU  A 601 ( 4.4A)
STU  A 601 ( 3.9A)
STU  A 601 (-4.3A)
STU  A 601 (-4.5A)
 0.78A 3fupA-5isoA:
26.1		 3fupA-5isoA:
22.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5iso 5'-AMP-ACTIVATED
PROTEIN KINASE
CATALYTIC SUBUNIT
ALPHA-2

(Homo sapiens) 		PF00069
(Pkinase)
PF16579
(AdenylateSensor) 		9 LEU A  22
GLY A  23
GLY A  28
VAL A  30
ALA A  43
MET A  93
TYR A  95
LEU A 146
ASP A 157
 STU  A 601 (-4.1A)
STU  A 601 (-3.4A)
992  A 602 ( 3.8A)
STU  A 601 (-4.8A)
STU  A 601 (-3.3A)
STU  A 601 ( 3.9A)
STU  A 601 (-4.3A)
STU  A 601 (-4.5A)
STU  A 601 (-3.5A)
 0.74A 3fupA-5isoA:
26.1		 3fupA-5isoA:
22.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5j5t MITOGEN-ACTIVATED
PROTEIN KINASE
KINASE KINASE KINASE
3

(Homo sapiens) 		PF00069
(Pkinase) 		8 GLY A  23
GLY A  28
VAL A  30
ALA A  43
LYS A  45
MET A  90
LEU A 143
ASP A 154
 None
None
6G2  A 901 ( 4.9A)
6G2  A 901 (-3.2A)
6G2  A 901 ( 3.9A)
6G2  A 901 (-3.5A)
6G2  A 901 (-4.7A)
6G2  A 901 (-3.4A)
 0.75A 3fupA-5j5tA:
22.9		 3fupA-5j5tA:
27.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5kbr SERINE/THREONINE-PRO
TEIN KINASE PAK 1

(Homo sapiens) 		PF00069
(Pkinase) 		9 GLY A 277
GLY A 279
GLY A 282
VAL A 284
ALA A 297
LYS A 299
TYR A 346
SER A 351
LEU A 396
 IPW  A 601 ( 3.9A)
None
None
IPW  A 601 (-4.2A)
IPW  A 601 (-3.5A)
IPW  A 601 (-4.5A)
IPW  A 601 (-4.5A)
None
IPW  A 601 (-4.5A)
 0.83A 3fupA-5kbrA:
23.0		 3fupA-5kbrA:
25.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5u94 SERINE/THREONINE-PRO
TEIN KINASE PKNB

(Mycobacterium
tuberculosis) 		no annotation 8 LEU A  17
GLY A  18
VAL A  25
ALA A  38
LYS A  40
MET A  92
TYR A  94
ASP A 156
 G93  A 301 ( 3.8A)
G93  A 301 ( 3.2A)
G93  A 301 (-3.4A)
G93  A 301 ( 3.7A)
G93  A 301 (-3.0A)
G93  A 301 (-2.7A)
None
G93  A 301 ( 3.2A)
 0.68A 3fupA-5u94A:
26.8		 3fupA-5u94A:
13.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5vil MITOGEN-ACTIVATED
PROTEIN KINASE
KINASE KINASE 5

(Homo sapiens) 		no annotation 10 LEU A 686
GLY A 687
GLY A 692
VAL A 694
ALA A 707
LYS A 709
MET A 754
SER A 761
LEU A 810
ASP A 822
 9E1  A1001 (-3.7A)
9E1  A1001 ( 3.4A)
None
9E1  A1001 ( 4.0A)
9E1  A1001 (-3.5A)
9E1  A1001 (-2.8A)
9E1  A1001 (-2.8A)
9E1  A1001 ( 3.9A)
9E1  A1001 (-4.5A)
9E1  A1001 (-3.6A)
 0.84A 3fupA-5vilA:
21.4		 3fupA-5vilA:
17.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5wno RECEPTOR
TYROSINE-PROTEIN
KINASE LET-23

(Caenorhabditis
elegans) 		no annotation 9 LEU A 891
GLY A 892
GLY A 894
GLY A 897
VAL A 899
ALA A 917
LYS A 919
TYR A 965
LEU A1017
 ANP  A1201 (-4.1A)
ANP  A1201 ( 3.8A)
ANP  A1201 (-2.8A)
None
ANP  A1201 (-4.4A)
ANP  A1201 (-3.3A)
ANP  A1201 (-3.8A)
ANP  A1201 (-4.4A)
ANP  A1201 (-4.7A)
 0.71A 3fupA-5wnoA:
27.7		 3fupA-5wnoA:
15.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6ao5 SERINE/THREONINE-PRO
TEIN KINASE 3

(Homo sapiens) 		no annotation 8 LEU A  33
GLY A  34
GLY A  39
VAL A  41
ALA A  54
LYS A  56
MET A  99
TYR A 101
 ANP  A 501 ( 3.8A)
ANP  A 501 ( 3.9A)
None
ANP  A 501 (-4.4A)
ANP  A 501 ( 3.7A)
ANP  A 501 (-2.4A)
ANP  A 501 (-2.5A)
ANP  A 501 ( 4.2A)
 0.80A 3fupA-6ao5A:
21.9		 3fupA-6ao5A:
28.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6bx6 5'-AMP-ACTIVATED
PROTEIN KINASE
CATALYTIC SUBUNIT
ALPHA-2

(Homo sapiens) 		no annotation 8 LEU A  22
GLY A  23
GLY A  25
GLY A  28
VAL A  30
ALA A  43
MET A  93
TYR A  95
 EDJ  A 301 (-3.9A)
EDJ  A 301 (-3.4A)
None
None
None
EDJ  A 301 (-3.4A)
EDJ  A 301 ( 4.2A)
EDJ  A 301 ( 4.8A)
 0.64A 3fupA-6bx6A:
18.4		 3fupA-6bx6A:
14.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6c7y TYROSINE-PROTEIN
KINASE JAK1

(Homo sapiens) 		no annotation 10 LEU A 881
GLY A 882
GLY A 884
GLY A 887
VAL A 889
ALA A 906
LYS A 908
MET A 956
SER A 963
LEU A1010
 ADP  A1201 ( 4.5A)
ADP  A1201 (-3.5A)
ADP  A1201 (-3.3A)
ADP  A1201 (-3.4A)
ADP  A1201 (-4.3A)
ADP  A1201 (-3.4A)
ADP  A1201 (-2.8A)
ADP  A1201 (-4.2A)
ADP  A1201 (-3.3A)
ADP  A1201 (-4.5A)
 0.76A 3fupA-6c7yA:
30.2		 3fupA-6c7yA:
24.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6f3d INTERLEUKIN-1
RECEPTOR-ASSOCIATED
KINASE 4

(Homo sapiens) 		no annotation 9 GLY A 193
GLY A 195
GLY A 198
VAL A 200
ALA A 211
LYS A 213
TYR A 264
SER A 269
LEU A 318
 CJT  A 502 ( 3.9A)
None
None
CJT  A 502 ( 4.8A)
CJT  A 502 (-3.4A)
CJT  A 502 (-3.0A)
CJT  A 502 (-4.5A)
CJT  A 502 ( 4.3A)
CJT  A 502 (-4.7A)
 0.79A 3fupA-6f3dA:
24.8		 3fupA-6f3dA:
12.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6fek PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE RECEPTOR RET

(Homo sapiens) 		no annotation 9 LEU A 730
GLY A 731
GLY A 733
GLY A 736
VAL A 738
ALA A 756
TYR A 806
SER A 811
LEU A 881
 ADN  A1104 ( 4.0A)
ADN  A1104 ( 3.9A)
ADN  A1104 ( 4.0A)
None
ADN  A1104 (-4.4A)
ADN  A1104 (-3.4A)
ADN  A1104 ( 4.1A)
ADN  A1104 (-3.7A)
ADN  A1104 (-4.3A)
 0.64A 3fupA-6fekA:
33.4		 3fupA-6fekA:
16.07